Radiofrequency Before to Surgical Removal of a Recalcitrant Morton´s Neuroma
REQUIEM
1 other identifier
interventional
34
1 country
1
Brief Summary
The purpose of this study is to perform a radiofrequency procedure prior to the removal of morton's neuroma. This procedure would be performed to check in which percentage of the nerve ablation has been performed, and whether the current protocol is performed correctly or parts of the nerve remain intact.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2022
CompletedFirst Posted
Study publicly available on registry
September 22, 2022
CompletedStudy Start
First participant enrolled
October 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2023
CompletedMay 10, 2023
May 1, 2023
1 month
September 19, 2022
May 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Nerve Damage
Anatomopathology of the nerve
1 week
Quality of Life, FFI
FFI Questionnaire
6 months
Study Arms (1)
Radiofrequency
EXPERIMENTALRadiofrequency procedure prior to the removal of morton's neuroma. * Radiofrequency Machine: Multilesion Generator 3 Channels TLG-10 STP. * Temperature: 80-85ºC * Time: 90 seconds * Active needle size: 1 cm * Number of Applications: 3 * Impedance: less than 550 * Ultrasound. General Electric Logic R7 with 12 Mgh probe.
Interventions
Peripheral ablation of affected Morton´s Neuroma nerve endings by thermal dissipation by an electrode.
Eligibility Criteria
You may qualify if:
- Patient aged between 18 and 70 years
- Patient with neuroma of morton of more than 1 year of evolution
- Patient treated by conservative treatments, stencils, various infiltrations, stretching and with symptomatology that limits his daily activities.
- Healthy patients without previous systemic pathologies (diabetes, coagulation or immunological disorders), ASA I or II that require and demand surgical treatment of their pathology in the participating centers and willing to participate in the study.
- freely accept and sign the informed consent for participation in the study.
You may not qualify if:
- Allergy to local anesthesia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alfonso Martínez Nova
Plasencia, Cáceres, 10600, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
September 19, 2022
First Posted
September 22, 2022
Study Start
October 15, 2022
Primary Completion
November 15, 2022
Study Completion
May 15, 2023
Last Updated
May 10, 2023
Record last verified: 2023-05